Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2020-08, Vol.55 (8), p.1655-1657
Main Authors: Abdallah, Nadine, Kim, Seongho, Ayash, Lois, Klimecki, Scott, Ventimiglia, Marie, Alavi, Asif, Ratanatharathorn, Voravit, Uberti, Joseph, Deol, Abhinav
Format: Article
Language:English
Subjects:
692/308/2171
692/700/565/2319
Autografts
Benzylamines
Biosimilar Pharmaceuticals
Cell Biology
Correspondence
Cyclams
Granulocyte Colony-Stimulating Factor
Hematology
Hematopoietic Stem Cell Mobilization
Heterocyclic Compounds
Humans
Internal Medicine
Medicine
Medicine & Public Health
Public Health
Stem Cell Transplantation
Stem Cells
Transplantation
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-019-0744-5